• 대한화장품학회지
• /
• 제45권1호
• /
• pp.49-56
• /
• 2019

분갈(Pueraria thomsonii Benth)은 전통적으로 중국 의학에서 발열, 급성 이질, 설사, 당뇨병 및 심혈관 질환 치료를 위한 약재로 사용되어 왔다. 이러한 분갈의 꽃인 분갈화의 피부 효능은 아직까지 밝혀진 바 없어, 본 연구에서는 멜라닌세포인 B16F1 세포주와 섬유아세포인 HS68 세포주를 이용하여 분갈화의 피부효능을 검증하고자 하였다. 분갈화의 에탄올 추출물이 멜라닌세포의 멜라닌 합성을 농도 의존적으로 감소시킴을 확인하고, 분갈화 추출물의 효능 성분을 추적하고자 high performance liquid chromatography (HPLC)를 이용하여 분석하였다. 그 결과, 분갈화에 함유된 이소플라본류 화합물인 tectorigenin, tectoridin, tectorigenin 7-O-xylosylglucoside 3종 성분을 확인하였다. 3종 성분 모두 독성을 보이지 않는 농도에서 멜라닌세포의 멜라닌 생합성을 농도 의존적으로 감소시켰으며, 이러한 멜라닌 생합성 감소는 tyrosinase와 microphthalmia-associated transcription factor (MITF) 유전자 발현을 감소시키는 것에 기인함을 확인하였다. 멜라닌 합성저해의 또 다른 기전을 확인하기 위하여, 섬유아세포에서 유래되는 멜라닌 합성억제 인자인 DKK-1의 발현에 대한 영향을 측정한 결과, 분갈화 추출물, tectoridin, tectorigenin 7-O-xylosylglucoside는 DKK-1의 발현을 농도 의존적으로 감소시킨 반면, tectorigenin은 DKK-1의 발현을 농도 의존적으로 증가시키는 것을 확인하였다. 이상의 연구 결과를 바탕으로, 분갈화 성분 중 tectorigenin은 멜라닌세포에서의 멜라닌 합성 억제와 섬유아세포에서의 멜라닌 생성 억제 인자 분비를 촉진하는 효과적인 미백 개선제로 활용할 수 있을 것으로 판단된다.

• 생약학회지
• /
• 제38권2호통권149호
• /
• pp.113-116
• /
• 2007

This study was carried out to obtain the basic information that can be used to index arrowroots (Pueraria species) in fourteen regions of China and Korea. The puerarin content in various arrowroots produced in the different areas were quantitatively analysed by HPLC. The average of puerarin content of the 'Galgeun' (Pueraria lobata) was higher than that of the 'Bungalgeun'(Pueraria thomsonii) produced in China and Korea. As a result, the order of the puerarin content was 1) Korean puerariae radix (P. lobata, 0.609%), 2) Chinese puerariae radix (P. lobata, 0.546%), 3) Chinese puerariae radix (P. thomsonii, 0.066%). This result showed that the content of puerarin in the 'Galgeun'(P. lobata) are about 10 times higher than those of the 'Bungalgeun'(P. thomsonii).

• 혜화의학회지
• /
• 제13권2호
• /
• pp.179-186
• /
• 2004

Now many sustitution and false articles is used in korea instead of gegen. To use gegen correctly, we will make a quilitative certificational plan of gegen to investigate all of lieraturea, records and documents. And we could reach conclusions as folloews. 1) Source As a source of gegen, we think all of Pueraria lobata Ohwi and Pueraria thomsonii Benth can be used in korea and china. 2) Harvesting time. According to a data, content of effective components is high when harvested in January and February. Though there is no problem because domestic harvesting and working time is between January and February, we think it need to sure well-founded datas. 3) Standars of goods According to cutting methods, gegen divide into 'jiaogegen' and 'piangegen' from users So there is no problem at cutting methods because it is not a affective factor. 4) Processing A processing method is a best important case in express quility of herb. According to a data, effective components of peeled gegen is much less than that of non-peeled geeen. A tested samples is non-peeled gegen at a researh, they received suitable judgments in all of items. Especially we got a result content of puerarin is much more than 2.0%. But they were not washed in water, it is a problem that there is bleaching effect by almost drying at a briquat. So a processing method is to wash in water with unavoidable turnning to brown, to prevent this grgrn must be dried in bulk at low temporature. And we think that content of puerarin must be looked upward.

• 셀메드
• /
• 제13권14호
• /
• pp.15.1-15.15
• /
• 2023

Background and objective: A new formular CPC22 consists of Cynanchum wilfordii root, Pueraria thomsonii flower, and Citrus unshiu peel and has been developed to improve the postmenopausal symptoms. The research intended to evaluate whether CPC22 would regulate bone loss, hot flashes, and dysregulated lipid metabolism in ovariectomized (OVX) postmenopausal mice. Method: The OVX mice were orally administered with CPC22 daily for 7 weeks. Results: CPC22 regulated OVX-induced bon loss by enhancing serum osteoprotegerin, alkaline phosphatase, and osteocalcin levels and diminishing serum receptor-activator of the NF-κB ligand (RANKL), collagen type 1 cross-linked N-telopeptide, and tartrate-resistant acid phosphatase levels. As a result of CPC22 treatment, notable decreases in tail skin temperature and rectal temperature were observed, along with diminishment in hypothalamic RANKL and monoamine oxidase A levels and enhancement in hypothalamic serotonin (5-HT), norepinephrine, dopamine, 5-HT2A, and estrogen receptor-β levels. CPC22 enhanced levels of serum estrogen and diminished levels of serum follicle-stimulating hormone and luteinizing hormone. CPC22 regulated levels of serum lipid metabolites, including total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. Furthermore, CPC22 diminished levels of serum blood urea nitrogen, creatine kinase, alanine transaminase, aspartate aminotransferase, and lactate dehydrogenase and restored vaginal dryness without affecting uterus atrophy index and vagina weights. Conclusion: Therefore, these results indicated that CPC22 improves OVX-induced bone loss, hot flashes, and dysregulated lipid metabolism by compensating for estrogen deficiency without side effects, suggesting that CPC22 may be used for the prevention and treatment of post menopause.